Pfizer Back To “Business As Normal”
Nov 16, 2018
For Immediate Release November 16, 2018 Contact: Lauren Blair (201) 213-5004… Read More
© 2024 CSRXP- All Rights Reserved
Press Release
Seventeen Groups Concerned About Out-Of-Control Drug Prices Urge Congress To Protect Seniors, Reject Big Pharma Bailout During Lame Duck
Nov 13, 2018
For Immediate Release Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies. Read More
CSRxP Launches Six-Figure, Multi-Phase Ad Campaign Targeted At Lawmakers Who Promised Lower Drug Prices
Nov 13, 2018
For Immediate ReleaseContact: Lauren Blair(201) [email protected]… Read More
CSRxP Statement on 2018 Midterm Election Results
Nov 7, 2018
Out-of-control drug prices was a prominent issue on the campaign trail. With… Read More
CSRxP Statement On The Trump Administration’s Proposal To Change Medicare Drug Prices
Oct 25, 2018
For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies… Read More
CSRxP Statement On PhRMA’s DTC Advertising Announcement
Oct 15, 2018
The Campaign for Sustainable Rx Pricing (CSRxP) issued the following statement… Read More
CSRxP Statement On HHS DTC Advertising Announcement
Oct 15, 2018
CSRxP issued the following statement in response to the U.S. Department of… Read More
Congress Rejects Big Pharma Bailout
Sep 26, 2018
Defeat For Price-Gouging Drug Manufacturers; Victory For Taxpayers &… Read More
CSRxP Urges Congress to Stop Big Pharma’s $4 Billion Bailout
Sep 25, 2018
Washington, D.C. – Today the Campaign for Sustainable Rx Pricing… Read More
CSRxP Urges House Members To Maintain Transparency Provision In Senate-Passed Appropriations Bill
Aug 29, 2018
CSRxP-Supported Policy Enables HHS To Require Drug Price Disclosure In… Read More
CSRxP Applauds Senate Action To Boost Drug Price Transparency For Consumers
Aug 24, 2018
Legislation Includes CSRxP-Supported Amendment Enabling HHS To Require… Read More
Statement on Celgene’s Revlimid Price Hike
Jul 10, 2018
CSRxP spokesman Will Holley released the following statement in response to… Read More